Pharmaceutical care program for patients with chronic kidney disease in the community pharmacy: detection of nephrotoxic drugs and dose adjustment. viability study

HIGHLIGHTS

• who: Gema Escribu00e1-Martu00ed et al. from the Pharmacist in L`Olleria, Valencia, Spain, Nephrologist, Nephrology Service, DrPeset University Hospital have published the research work: Pharmaceutical care program for patients with chronic kidney disease in the community pharmacy: Detection of nephrotoxic drugs and dose adjustment. Viability study, in the Journal: PLOS ONE of July/30,/2022
• what: If the authors focus only on the patients with stage 3 CKD (eGFR between 30 and 60), the authors see that the intervention is more efficient as the authors achieve better results. The study showed that an average . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.